Ten incredibly inventive companies have joined Medidata's ground-breaking Sensor Cloud Network, according to the Dassault Systèmes firm. The first cross-sector partnership is now made up of AliveCor, Aural Analytics, Biobeat, Blue Spark Technologies, Glooko, Indie Health, University of Arizona, Carnegie Mellon University, University of Rochester, and University of Vermont. Its goals include resolving issues with sensor integration, standardizing sensor data, and creating new digital biomarkers and algorithms. These will contribute to the development of new digital endpoints that might lead to the development of more potent therapies and improved patient care.
The Sensor Cloud Network offers data scientists the chance to develop, test, and deliver physiological algorithms with clinical relevance at scale. The network consists of contract research organizations (CROs), device manufacturers, drug and vaccine developers, analytics firms, and academic institutions. Detailed motion characteristics including gait, cardiovascular measures, metabolic insights, and voice analytics of the highest caliber are a few examples.
“As the use of sensors in clinical trials is predicted to reach 50% by 20251, we are focused on making Medidata Sensor Cloud the industry standard for collecting and analyzing medical-grade sensor data. “We are excited to work with a diverse group of partners to help shape the future of patient data collection and analysis, and make Sensor Cloud the platform of choice for developing new digital biomarkers across a wide variety of therapeutic areas.”
Ben Schlatka, Vice President, Digital Biomarker Solutions, Medidata